Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GLAXOSMITHKLINE Latest News

JUL 30, 2015 - Zacks Investment Research

A Must Read - Share

Glaxo Up on Q2 Earnings Beat, Revenues Rise, View Same - Analyst Blog

GlaxoSmithKline (GSK) reported second-quarter 2015 core earnings of 53 cents per American depositary share, beating the Zacks Consensus Estimate by 3 cents.

Tags: Glaxo Up on Q2 Earnings Beat, Revenues Rise, View Same - Analyst Blog,  Glaxosmithkline Latest News

JUL 30, 2015 - Zero Hedge

A Must Read - Share

Frontrunning: July 30

Second-quarter GDP seen rebounding on consumer spending, housing (Reuters) China Stocks Fall as Traders Puzzle Over Sudden Late-Day Swings (BBG) Dents and Scratches May Hold Crash Clues for MH370 Investigators (BBG) European 'alliance of national liberation fronts' emerges to avenge Greek defeat (Telegraph) Thomas Cook warns on earnings over Greece (MW) Largest Greek toy seller Jumbo warns of hit from ...

Tags: Frontrunning: July 30,  Glaxosmithkline Latest News

JUL 29, 2015 - BBC

A Must Read - Share

GlaxoSmithKline sees big profits fall

Pharmaceuticals giant GlaxoSmithKline (GSK) sees a big fall in second-quarter earnings amid continued pressure from generic drugmakers.

Tags: GlaxoSmithKline sees big profits fall,  Glaxosmithkline Latest News

JUL 29, 2015 - Wall Street Journal

A Must Read - Share

GSK Boosted by New Vaccines

GlaxoSmithKline reported a 6% rise in second-quarter revenue to $9.19 billion, boosted by new vaccines and consumer health-care products from its $20 billion asset swap with Novartis and a strong performance from its HIV business ViiV Healthcare.

Tags: GSK Boosted by New Vaccines,  Glaxosmithkline Latest News

JUL 29, 2015 - Reuters

A Must Read - Share

GSK flags up pipeline as HIV drugs help it beat profit forecasts

LONDON (Reuters) - GlaxoSmithKline moved to reclaim its prowess as a research powerhouse on Wednesday by flagging up dozens of new drugs and vaccines in development, as demand for new HIV medicines helped it beat quarterly profit forecasts.

Tags: GSK flags up pipeline as HIV drugs help it beat profit forecasts,  Glaxosmithkline Latest News